Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford University and Novo Nordisk have announced the establishment of an international postdoctoral fellowship programme to support research within the fields of diabetes, metabolism and endocrinology.

A total of 12 postdoctoral fellowships will be awarded, each for a 3 year period. The fellows will be hosted by Oxford University and funded by Novo Nordisk. The goal of the programme is to support the development of a new generation of research leaders while further developing scientific excellence within diabetes.

The programme will be coordinated through the Radcliffe Department of Medicine (RDM). The first four fellows in the programme will start in the autumn of 2014. Full details on the programme will be available shortly. Any queries should be directed to Dr Ruth McCaffrey.

The full text of the release is available.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

New heart disease calculator could save lives by identifying high-risk patients missed by current tools

Collaborative research, led from NDPCHS and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.